Optimal therapy for concomitant EGFR and TP53 mutated non-small cell lung cancer: a real-world study.
Sun H, Ren P, Chen Y, Lan L, Yan Z, Yang Y, Wang B, Wang C, Li Y, Li L, Zhang Y, Li Y, Wang Z, Pan Z, Jiang Z.
Sun H, et al. Among authors: wang z, wang c, wang b.
BMC Cancer. 2023 Mar 2;23(1):198. doi: 10.1186/s12885-023-10637-4.
BMC Cancer. 2023.
PMID: 36864384
Free PMC article.